Novo Nordisk shares climbed 8% on Thursday after the Danish pharmaceutical giant reported positive early trial data for a new weight loss drug.
© 2010-2022 Billy Tang
Supported By Growth SpeedUp Company
© 2010-2022 Billy Tang
Supported By Growth SpeedUp Company
Subscribe now to keep reading and get access to the full archive.